Delivery of viral-vectored vaccines by B cells represents a novel strategy to accelerate CD8(+) T-cell recall responses.

Rapid boosting of memory CD8(+) T cells (TM) is essential in cancer immunotherapy and the control of certain infectious diseases. However, effector T cells (TE) are a barrier to booster vaccination because they can rapidly kill antigen-bearing antigen-presenting cells (APCs) before TM are engaged. We demonstrate that viral-vectored vaccines delivered by B cells elicit robust TM expansion in the presence of TE, enabling booster immunizations to bypass TE-mediated negative feedback regulation. Our data indicate that viral vector-loaded B cells home to the follicular regions in secondary lymphoid organs, which are anatomically separated from TE and in close proximity to TM. The B cells, however, do not serve as APCs in this area. Rather, classic CD11c(+) dendritic cells serve to stimulate the secondary CD8(+) T-cell response. Our data reveal that B cells represent a novel and readily accessible delivery system that can effectively engage secondary CD8(+) T-cell activation for prime-boost strategies.

[1]  P. Ashton‐Rickardt,et al.  Serine Protease Inhibitor 6 Is Required To Protect Dendritic Cells from the Kiss of Death , 2012, The Journal of Immunology.

[2]  J. Schlom,et al.  Viral vector-based therapeutic cancer vaccines. , 2011, Cancer journal.

[3]  A. Hill,et al.  Viral vectors as vaccine platforms: deployment in sight. , 2011, Current opinion in immunology.

[4]  J. Boudreau,et al.  CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells. , 2011, Blood.

[5]  J. Boudreau,et al.  T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells , 2011 .

[6]  Nikhil S. Joshi,et al.  Differential Localization of Effector and Memory CD8 T Cell Subsets in Lymphoid Organs during Acute Viral Infection , 2010, The Journal of Immunology.

[7]  Eleanor Pullenayegum,et al.  Potentiating cancer immunotherapy using an oncolytic virus. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  J. Boudreau,et al.  Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  J. Boudreau,et al.  Recombinant vesicular stomatitis virus transduction of dendritic cells enhances their ability to prime innate and adaptive antitumor immunity. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  J. Boudreau,et al.  Culture of myeloid dendritic cells from bone marrow precursors. , 2008, Journal of visualized experiments : JoVE.

[11]  I. Williams,et al.  Differential Microenvironment Localization of Effector and Memory CD8 T Cells1 , 2008, The Journal of Immunology.

[12]  J. Gauldie,et al.  Antigen Presentation by Exosomes Released from Peptide-Pulsed Dendritic Cells Is not Suppressed by the Presence of Active CTL1 , 2007, The Journal of Immunology.

[13]  L. Lefrançois,et al.  In Situ Imaging of the Endogenous CD8 T Cell Response to Infection , 2007, Science.

[14]  Ronald N Germain,et al.  L-selectin-negative CCR7− effector and memory CD8+ T cells enter reactive lymph nodes and kill dendritic cells , 2007, Nature Immunology.

[15]  Matthew D. H. Lay,et al.  Killer T cells regulate antigen presentation for early expansion of memory, but not naive, CD8+ T cell , 2007, Proceedings of the National Academy of Sciences.

[16]  D. Zelterman,et al.  Vesicular Stomatitis Virus-Based Therapeutic Vaccination Targeted to the E1, E2, E6, and E7 Proteins of Cottontail Rabbit Papillomavirus , 2007, Journal of Virology.

[17]  J. Villadangos,et al.  Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. , 2006, Immunity.

[18]  Scott N. Mueller,et al.  CD4+ T Cells Can Protect APC from CTL-Mediated Elimination1 , 2006, The Journal of Immunology.

[19]  L. Fernando,et al.  Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment , 2006, The Lancet.

[20]  D. Spaner,et al.  Sensitization of IL-2 Signaling through TLR-7 Enhances B Lymphoma Cell Immunogenicity1 , 2006, The Journal of Immunology.

[21]  Franca Ronchese,et al.  Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Arend Heerschap,et al.  Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy , 2005, Nature Biotechnology.

[23]  Xian-Yang Zhang,et al.  LSU Digital Commons LSU Digital Commons Altering the tropism of lentiviral vectors through pseudotyping Altering the tropism of lentiviral vectors through pseudotyping , 2022 .

[24]  G. Belz,et al.  Transfer of antigen between migrating and lymph node-resident DCs in peripheral T-cell tolerance and immunity. , 2004, Trends in immunology.

[25]  J. Schultze,et al.  DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy. , 2004, Trends in immunology.

[26]  E. Pamer,et al.  Rapid Development of T Cell Memory1 , 2004, The Journal of Immunology.

[27]  David L Woodland,et al.  Jump-starting the immune system: prime-boosting comes of age. , 2004, Trends in immunology.

[28]  R. Brutkiewicz,et al.  Myeloid marker expression on antiviral CD8+ T cells following an acute virus infection , 2003, European journal of immunology.

[29]  P. Hwu,et al.  CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells. , 2003, Cancer research.

[30]  E. Pamer,et al.  Feedback regulation of pathogen-specific T cell priming. , 2003, Immunity.

[31]  M. Tanimoto,et al.  Efficient Generation of Antigen-Specific Cytotoxic T Cells Using Retrovirally Transduced CD40-Activated B Cells1 , 2002, The Journal of Immunology.

[32]  K. Anderson,et al.  Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application. , 2002, Blood.

[33]  J. Yewdell,et al.  Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo , 2002, Nature Immunology.

[34]  Wolfgang Weninger,et al.  Migratory Properties of Naive, Effector, and Memory Cd8+ T Cells , 2001, The Journal of experimental medicine.

[35]  David Montefiori,et al.  An Effective AIDS Vaccine Based on Live Attenuated Vesicular Stomatitis Virus Recombinants , 2001, Cell.

[36]  I. Hermans,et al.  Killing of Dendritic Cells , 2001, The Journal of experimental medicine.

[37]  T. Schumacher,et al.  Expression of the Serpin Serine Protease Inhibitor 6 Protects Dendritic Cells from Cytotoxic T Lymphocyte–Induced Apoptosis , 2001, The Journal of experimental medicine.

[38]  R. Zinkernagel,et al.  Perforin‐independent regulation of dendritic cell homeostasis by CD8+ T cells in vivo: implications for adaptive immunotherapy , 2001, European journal of immunology.

[39]  L. Lefrançois,et al.  Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue , 2001, Science.

[40]  A. Roberts,et al.  Glycoprotein Exchange Vectors Based on Vesicular Stomatitis Virus Allow Effective Boosting and Generation of Neutralizing Antibodies to a Primary Isolate of Human Immunodeficiency Virus Type 1 , 2000, Journal of Virology.

[41]  K. Rock,et al.  Bone Marrow–Derived Antigen-Presenting Cells Are Required for the Generation of Cytotoxic T Lymphocyte Responses to Viruses and Use Transporter Associated with Antigen Presentation (Tap)-Dependent and -Independent Pathways of Antigen Presentation , 2000, The Journal of experimental medicine.

[42]  Joanna M. Roberts,et al.  CD8+ T Cell-Dependent Elimination of Dendritic Cells In Vivo Limits the Induction of Antitumor Immunity1 , 2000, The Journal of Immunology.

[43]  H. Pircher,et al.  Distinct migration patterns of naive and effector CD8 T cells in the spleen: correlation with CCR7 receptor expression and chemokine reactivity , 1999, European journal of immunology.

[44]  M. Plebanski,et al.  Induction of CD8+ T cells using heterologous prime‐boost immunisation strategies , 1999, Immunological reviews.

[45]  F. Sallusto,et al.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.

[46]  R. Coleman,et al.  Migration of human dendritic cells after injection in patients with metastatic malignancies. , 1999, Cancer research.

[47]  L. Lefrançois,et al.  Antigen-driven induction of CD11c on intestinal intraepithelial lymphocytes and CD8+ T cells in vivo. , 1995, Journal of immunology.

[48]  J. Whitton,et al.  Vaccination to prevent persistent viral infection , 1993, Journal of virology.